https://www.selleckchem.com/pr....oducts/hmpl-504-azd6
In April 2012, the Manitoba Home Cancer Drug Program (HCDP) was introduced to allow 100% coverage for eligible oral anticancer agents (OAA) and supportive medications for Manitobans with cancer requiring these therapies. What is the extent of use and cost of OAAs among outpatients in Manitoba from 2003/04 to 2015/16? Did the HCDP change OAA user and prescription patterns? This was a retrospective, population-based study using administrative data to measure the prevalence of drug utilization over time and the impact of